1. World Health Organization. Global status report on non-communicable diseases 2010. http://www.who.int/nmh/publications/ncd_report_full_en.pdf
2. World Health Organization. Global atlas on cardiovascular disease prevention and control 2011. http://www.who.int/nmh/publications/ncd_profiles_report.pdf
3. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Medicine 2006;3(11):442. DOI: 10.1371/journal.pmed.0030442
4. Usman A., Ribbatti D., Sadat U., Gillard J.H. From lipid retention to immune-mediate inflammation and associated angiogenesis in the pathogenesis of atherosclerosis. Journal of Atheroscler Thromb 2015;22(8):739–749. DOI: 10.5551/jat.30460
5. Virmani R., Kolodgie F.D., Burke A.P. et al. Lessons from sudden coronary death: a comprehensive morphological classification sheme for atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 2000;20(5):1262–1275. DOI: 10.1161/01.ATV.20.5.1262
6. Stoger J.L., Gijbels M.J., van der Velden S. et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012;225(2):461–468. DOI:10.1016/j.atherosclerosis.2012.09.013
7. Tesauro M., Mauriello A., Rovella V. et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Int Med 2017;281(5):471–482. DOI: 10.1111/joim.12605.
8. Tabas I., Bornfeldt K.E. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res 2016;118(4):653– 667. DOI:10.1161/CIRCRESAHA.115/306256
9. Pathology. National guidebook. Moscow, 2011. Russian (Патологическая анатомия. Национальное руководство. М., 2011).
10. Marx S.O., Totary-Jain H., Marks A.R. Vascular smooth muscle cell proliferation in restenosis. Circulation: Cardiovasc Interv 2011;4(1):104–111. DOI: 10.116/CIRCINTERVENTIONS.110.967332
11. Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116(16):1832–1844. DOI:10.1161/CIRCULATIONAHA.106.676890
12. Chinetti-Gbaguidi G., Colin S., Staels B. Macrophage subsets in atherosclerosis. Nature Reviews Cardiology 2015;12(1):10–17. DOI: 10.1038/nrcardio.2014.173
13. Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atheroscleosis. Cardiovasc Res 2012;95(2):156–164. DOI: 10.1093/cvr/cvs115
14. Allahverdian S., Chehroudi A.C., McManus B.M. et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation 2014;129(15):1551–1559. DOI: 10.1161/CIRCULATIONAHA.113.005015
15. Sukhovershin R.A., Toledano Furman N.E. et al. Local inhibition of macrophage and smooth muscle cell proliferation to suppress plaque progression. Methodist DeBakey Cardiovasc J 2016;12 (3):141–145. DOI: 10.14797/mdcj-12-3-141
16. Todorov S.S. Smooth muscle cells in cardiovascular pathology. Rossiisky kardiologicheskyi zhurnal 2009;5(79):91–94. Russian (Тодоров С.С. Гладкие миоциты в патологии сердечно-сосудистой системы. Российский кардиологический журнал 2009;5(79):91–94.)
17. Klimov A.N., Nikulcheva N.G. Exchange of lipids and lipoproteins and its violation. A Practical Guide. Moscow.1999. Russian (Климов А.Н., Никульчева Н.Г. Обмен липидов и липопротеидов и его нарушения. Практическое руководство. М., 1999).
18. Nagornev V.A. Pathogenesis of atherosclerosis. Moscow, 2006. 240p. Russian (Нагорнев В.А. Патогенез атеросклероза. М., 2006, 240 с).
